These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35817542)

  • 1. Targeting Angiogenesis via Resolution of Inflammation.
    Kelly AG; Panigrahy D
    Cold Spring Harb Perspect Med; 2023 Mar; 13(3):. PubMed ID: 35817542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specialized pro-resolving mediators in cardiovascular diseases.
    Fredman G; Spite M
    Mol Aspects Med; 2017 Dec; 58():65-71. PubMed ID: 28257820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Pharmacology of Inflammation Resolution in Atherosclerosis.
    Kotlyarov S; Kotlyarova A
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro-resolving lipid mediators in the resolution of neointimal hyperplasia pathogenesis in atherosclerotic diseases.
    Satish M; Agrawal DK
    Expert Rev Cardiovasc Ther; 2019 Mar; 17(3):177-184. PubMed ID: 30582389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro-resolving lipid mediators: Agents of anti-ageing?
    Doyle R; Sadlier DM; Godson C
    Semin Immunol; 2018 Dec; 40():36-48. PubMed ID: 30293857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
    Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
    Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomimetic Nanocarriers of Pro-Resolving Lipid Mediators for Resolution of Inflammation in Atherosclerosis.
    Anghelache M; Voicu G; Deleanu M; Turtoi M; Safciuc F; Anton R; Boteanu D; Fenyo IM; Manduteanu I; Simionescu M; Calin M
    Adv Healthc Mater; 2024 Jan; 13(3):e2302238. PubMed ID: 37852632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of T-Cell Immune Responses by Pro-Resolving Lipid Mediators.
    Perez-Hernandez J; Chiurchiù V; Perruche S; You S
    Front Immunol; 2021; 12():768133. PubMed ID: 34868025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specialized pro-resolving lipid mediators in endodontics: a narrative review.
    Aubeux D; Peters OA; Hosseinpour S; Tessier S; Geoffroy V; Pérez F; Gaudin A
    BMC Oral Health; 2021 May; 21(1):276. PubMed ID: 34030680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specialized Pro-resolving Mediators Directs Cardiac Healing and Repair with Activation of Inflammation and Resolution Program in Heart Failure.
    Halade GV; Tourki B
    Adv Exp Med Biol; 2019; 1161():45-64. PubMed ID: 31562621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherosclerosis is a major human killer and non-resolving inflammation is a prime suspect.
    Fredman G; MacNamara KC
    Cardiovasc Res; 2021 Nov; 117(13):2563-2574. PubMed ID: 34609505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From Inflammation to Resolution: Specialized Pro-resolving Mediators in Posttraumatic Osteoarthritis.
    Leite CBG; Merkely G; Charles JF; Lattermann C
    Curr Osteoporos Rep; 2023 Dec; 21(6):758-770. PubMed ID: 37615856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resolution of inflammation: An organizing principle in biology and medicine.
    Panigrahy D; Gilligan MM; Serhan CN; Kashfi K
    Pharmacol Ther; 2021 Nov; 227():107879. PubMed ID: 33915177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specialized Pro-Resolving Lipid Mediators: New Therapeutic Approaches for Vascular Remodeling.
    Díaz Del Campo LS; Rodrigues-Díez R; Salaices M; Briones AM; García-Redondo AB
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation.
    Recchiuti A; Serhan CN
    Front Immunol; 2012; 3():298. PubMed ID: 23093949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolution of Inflammation in Retinal Disorders: Briefly the State.
    Trotta MC; Gesualdo C; Petrillo F; Lepre CC; Della Corte A; Cavasso G; Maggiore G; Hermenean A; Simonelli F; D'Amico M; Rossi S
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mediators and mechanisms in the resolution of infectious inflammation: evidence for vagus regulation.
    Serhan CN; de la Rosa X; Jouvene C
    J Intern Med; 2019 Sep; 286(3):240-258. PubMed ID: 30565762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolvins: Emerging Players in Autoimmune and Inflammatory Diseases.
    Abdolmaleki F; Kovanen PT; Mardani R; Gheibi-Hayat SM; Bo S; Sahebkar A
    Clin Rev Allergy Immunol; 2020 Feb; 58(1):82-91. PubMed ID: 31267470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of pro-resolving mediators in diabetic kidney disease.
    Vartak T; Godson C; Brennan E
    Adv Drug Deliv Rev; 2021 Nov; 178():113965. PubMed ID: 34508793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into the role of the resolvin D2-GPR18 signaling axis in cardiovascular physiology and disease.
    Spite M; Fredman G
    Adv Pharmacol; 2023; 97():257-281. PubMed ID: 37236761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.